NEW YORK (GenomeWeb) – Berry Genomics announced today that it has formed a collaboration with BioNano Genomics to develop assays for the detection of chromosomal variations for the Chinese market.

Under the terms of their deal, the companies will co-develop assays that incorporate BioNano's Irys next-generation mapping platform, which is designed to image, map, and analyze DNA at the single-molecule level to reveal structural variation and aid in genome assembly.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.